T2 Biosystems Inc Share Price Today: Live Updates & Key Insights

T2 Biosystems Inc share price today is $0.112, up -31.07%. The stock opened at $0.11 against the previous close of $0.1944, with an intraday high of $0.155 and low of $0.11.

T2 Biosystems Inc Share Price Chart

T2 Biosystems Inc

us-stock
To Invest in {{usstockname}}
us-stock

T2 Biosystems Inc Share Price Performance

$0.112 -0.3107(-31.07%) TTOO at 23 Mar 2026 03:36 PM Diagnostics & Research
Lowest Today 0.11
Highest Today 0.155
Today’s Open 0.11
Prev. Close 0.1944
52 Week High 6.95
52 Week Low 0.11
Day’s Range: Low 0.11 High 0.155
52-Week Range: Low 0.11 High 6.95
1 day return -
1 Week return -
1 month return -
3 month return -
6 month return -
1 year return -
3 year return -99.76
5 year return -99.99
10 year return -

T2 Biosystems Inc Institutional Holdings

Armistice Capital, LLC 4.98

Vanguard Group Inc 1.39

Vanguard Total Stock Mkt Idx Inv 0.55

Geode Capital Management, LLC 0.32

BlackRock Inc 0.27

Spartan Total Market Index Pool E 0.24

State Street Corp 0.23

Susquehanna International Group, LLP 0.16

Extended Equity Market Fund K 0.14

Millennium Management LLC 0.14

Fidelity Extended Market Index 0.13

Northern Trust Corp 0.10

Fidelity Total Market Index 0.08

Kingswood Wealth Advisors LLC 0.07

Northern Trust Extended Eq Market Idx 0.06

NT Ext Equity Mkt Idx Fd - L 0.06

Goldman Sachs Group Inc 0.05

NT Ext Equity Mkt Idx Fd - NL 0.04

Fidelity Nasdaq Composite Index 0.03

Fidelity Series Total Market Index 0.03

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.03

Extended Equity Market Fund M 0.02

State St US Extended Mkt Indx NL Cl C 0.02

Royal Bank of Canada 0.01

NT Ext Eq Mkt Indx Fd DC Lend T3 0.01

NT Ext Eq Mkt Indx Fd DC Lend T4 0.01

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.01

Tower Research Capital LLC 0.01

BNYM Mellon SL Market Completion UC1 0.01

SSgA U.S. Total Market Index Strategy 0.01

Northern Trust Wilshire 5000 0.00

Group One Trading, LP 0.00

Spartan Extended Market Index Pool E 0.00

Advisor Group Holdings, Inc. 0.00

Barclays PLC 0.00

Bank of America Corp 0.00

International Assets Investment Management, LLC 0.00

Morgan Stanley - Brokerage Accounts 0.00

UBS Group AG 0.00

U.S. Bancorp 0.00

T2 Biosystems Inc Market Status

Strong Buy: 0

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

T2 Biosystems Inc Fundamentals

Market Cap 10.48 M

PB Ratio 14.5044

PE Ratio 0.0

Enterprise Value 22.31 M

Total Assets 34.80 M

Volume 15084144

T2 Biosystems Inc Company Financials

Annual Revenue FY23:10997000 11.0M, FY22:22305000 22.3M, FY21:28058000 28.1M, FY20:18130000 18.1M, FY19:8335000 8.3M

Annual Profit FY23:-5522000 -5.5M, FY22:1166000 1.2M, FY21:7355000 7.4M, FY20:-3150000 -3.2M, FY19:-8428000 -8.4M

Annual Net worth FY23:-49836000 -49.8M, FY22:-63370000 -63.4M, FY21:-53495000 -53.5M, FY20:-49208000 -49.2M, FY19:-63112000 -63.1M

Quarterly Revenue Q3/2024:1985000 2.0M, Q2/2024:1952000 2.0M, Q1/2024:2061000 2.1M, Q4/2023:1679000 1.7M, Q3/2023:1472000 1.5M

Quarterly Profit Q3/2024:-2116000 -2.1M, Q2/2024:-741000 -0.7M, Q1/2024:-2141000 -2.1M, Q4/2023:-895000 -0.9M, Q3/2023:-2453000 -2.5M

Quarterly Net worth Q3/2024:-10117000 -10.1M, Q2/2024:-8963000 -9.0M, Q1/2024:-13534000 -13.5M, Q4/2023:-10340000 -10.3M, Q3/2023:-15425000 -15.4M

About T2 Biosystems Inc & investment objective

Company Information T2 Biosystems, Inc., an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood molecular diagnostic test panel that detects lethal form of common blood stream infections, which cause sepsis and candidemia; T2Bacteria panel, a direct-from-blood molecular diagnostic test panel, which detects bacterial pathogens in blood stream infections; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2Biothreat, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument and detects biothreat pathogens. In addition, it is developing T2Cauris panel, a direct-from-blood molecular diagnostic test that runs on the T2Dx Instrument and detects Candida auris; and T2Lyme panel, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument to identify the bacteria that cause Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

Organisation Diagnostics & Research

Employees 113

Industry Diagnostics & Research

CEO Mr. John J. Sperzel III, B.Sc.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

T2 Biosystems Inc FAQs

What is the share price of T2 Biosystems Inc today?

The current share price of T2 Biosystems Inc is $0.112.

Can I buy T2 Biosystems Inc shares in India?

Yes, Indian investors can buy T2 Biosystems Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy T2 Biosystems Inc shares in India?

You can easily invest in T2 Biosystems Inc shares from India by:

Can I buy fractional shares of T2 Biosystems Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of T2 Biosystems Inc?

T2 Biosystems Inc has a market cap of $10.48 M.

In which sector does T2 Biosystems Inc belong?

T2 Biosystems Inc operates in the Diagnostics & Research sector.

What documents are required to invest in T2 Biosystems Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of T2 Biosystems Inc?

The PE ratio of T2 Biosystems Inc is N/A and the PB ratio is 14.50.